{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:52:50Z","timestamp":1794527570512,"version":"4.9.1"},"reference-count":88,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2013,7,11]]},"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>Screening for Fabry disease (FD) reveals a high prevalence of individuals with \u03b1-galactosidase A (GLA) genetic variants of unknown significance (GVUS). These individuals often do not express characteristic features of FD. A systematic review on FD screening studies was performed to interpret the significance of GLA gene variants and to calculate the prevalence of definite classical and uncertain cases. We searched PubMed and Embase for screening studies on FD. We collected data on screening methods, clinical, biochemical and genetic assessments. The pooled prevalence of identified subjects and those with a definite diagnosis of classical FD were calculated. As criteria for a definite diagnosis, we used the presence of a GLA variant, absent or near-absent leukocyte enzyme activity and characteristic features of FD. Fifty-one studies were selected, 45 in high-risk and 6 in newborn populations. The most often used screening method was an enzyme activity assay. Cut-off values comprised 10\u201355% of the mean reference value for men and up to 80% for women. Prevalence of GLA variants in newborns was 0.04%. In high-risk populations the overall prevalence of individuals with GLA variants was 0.62%, while the prevalence of a definite diagnosis of FD was 0.12%. The majority of identified individuals in high-risk and newborn populations harbour GVUS or neutral variants in the GLA gene. To determine the pathogenicity of a GVUS in an individual, improved diagnostic criteria are needed. We propose a diagnostic algorithm to approach the individual with an uncertain diagnosis.<\/jats:p>","DOI":"10.1136\/jmedgenet-2013-101857","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T01:32:31Z","timestamp":1375839151000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":158,"title":["A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance"],"prefix":"10.1136","volume":"51","author":[{"given":"L","family":"van der Tol","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B E","family":"Smid","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J H M","family":"Poorthuis","sequence":"additional","affiliation":[{"name":"Laboratory of Genetic Metabolic Diseases, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Biegstraaten","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H Lekanne","family":"Deprez","sequence":"additional","affiliation":[{"name":"Clinical Genetics, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G E","family":"Linthorst","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E M","family":"Hollak","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam Lysosome Center \u2018Sphinx\u2019, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,8,6]]},"reference":[{"key":"2025101710571776000_51.1.1.1","unstructured":"Desnick RJ Ioannou YA Eng CM . Chapter 150: alpha-galactosidase a deficiency: fabry disease. the online metabolic and molecular bases of inherited disease. 8th ed. McGraw Hill, 2007:3733\u201374."},{"key":"2025101710571776000_51.1.1.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"2025101710571776000_51.1.1.3","doi-asserted-by":"publisher","DOI":"10.1007\/s004399900075"},{"key":"2025101710571776000_51.1.1.4","unstructured":"The Human Genome Mutation Database. 2013. http:\/\/www.hgmd.org.. 1-6-2013."},{"key":"2025101710571776000_51.1.1.5","first-page":"247","article-title":"Structure-function relationships in alpha-galactosidase A","volume":"1802","author":"Garman","year":"2007","journal-title":"Acta Paediatr Suppl"},{"key":"2025101710571776000_51.1.1.6","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2005.036327"},{"key":"2025101710571776000_51.1.1.7","unstructured":"Mehta A Hughes DA . Fabry disease. 1993. GeneReviews\u2122 [Internet] http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1292\/. Initial Posting: 5 August, 2002; Last Update: 10 Mar 2011.."},{"key":"2025101710571776000_51.1.1.8","doi-asserted-by":"publisher","DOI":"10.1086\/504601"},{"key":"2025101710571776000_51.1.1.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.109.862920"},{"key":"2025101710571776000_51.1.1.10","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21074"},{"key":"2025101710571776000_51.1.1.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61266-X"},{"key":"2025101710571776000_51.1.1.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712309105"},{"key":"2025101710571776000_51.1.1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.09.026"},{"key":"2025101710571776000_51.1.1.14","doi-asserted-by":"publisher","DOI":"10.1021\/ac303033v"},{"key":"2025101710571776000_51.1.1.15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jchromb.2011.11.020","article-title":"Quantification of the Fabry marker lysoGb3 in human plasma by tandem mass spectrometry","volume":"883\u2013884","author":"Kruger","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2025101710571776000_51.1.1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.03.020"},{"key":"2025101710571776000_51.1.1.17","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2012.192138"},{"key":"2025101710571776000_51.1.1.18","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(81)90384-3"},{"key":"2025101710571776000_51.1.1.19","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10275"},{"key":"2025101710571776000_51.1.1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.10.018"},{"key":"2025101710571776000_51.1.1.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.01.010"},{"key":"2025101710571776000_51.1.1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.062"},{"key":"2025101710571776000_51.1.1.23","doi-asserted-by":"publisher","DOI":"10.1080\/08860220802353777"},{"key":"2025101710571776000_51.1.1.24","doi-asserted-by":"publisher","DOI":"10.1007\/s101570050061"},{"key":"2025101710571776000_51.1.1.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67635-0"},{"key":"2025101710571776000_51.1.1.26","unstructured":"Exome Variant Server. 2013. http:\/\/evs.gs.washington.edu\/. 19-2-2013."},{"key":"2025101710571776000_51.1.1.27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.593558"},{"key":"2025101710571776000_51.1.1.28","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.8.929"},{"key":"2025101710571776000_51.1.1.29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2230.2009.03721.x","article-title":"Angiokeratoma: a cutaneous marker of Fabry's disease","volume":"35","author":"Albano","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"2025101710571776000_51.1.1.30","doi-asserted-by":"publisher","DOI":"10.1051\/medsci\/20052111s53"},{"key":"2025101710571776000_51.1.1.31","first-page":"677","article-title":"[Fabry's disease: role of screening in populations at risk, in the image of chronic hemodialyzed patients]","volume":"124","author":"Bekri","year":"2004","journal-title":"Rev Med Suisse Romande"},{"key":"2025101710571776000_51.1.1.32","first-page":"11","article-title":"Prevalence of hereditary renal disease","volume":"83","author":"Green","year":"1990","journal-title":"Ir Med J"},{"key":"2025101710571776000_51.1.1.33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.110.958835"},{"key":"2025101710571776000_51.1.1.34","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200109270-00016"},{"key":"2025101710571776000_51.1.1.35","doi-asserted-by":"publisher","DOI":"10.1159\/000076846"},{"key":"2025101710571776000_51.1.1.36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2008.00791.x"},{"key":"2025101710571776000_51.1.1.37","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000124671.61963.1E"},{"key":"2025101710571776000_51.1.1.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033349"},{"key":"2025101710571776000_51.1.1.39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000139847.74101.03"},{"key":"2025101710571776000_51.1.1.40","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300364"},{"key":"2025101710571776000_51.1.1.41","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.200188"},{"key":"2025101710571776000_51.1.1.42","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq073"},{"key":"2025101710571776000_51.1.1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.10.076"},{"key":"2025101710571776000_51.1.1.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508033330504"},{"key":"2025101710571776000_51.1.1.45","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012626.81324.38"},{"key":"2025101710571776000_51.1.1.46","doi-asserted-by":"crossref","unstructured":"Terryn W Deschoenmakere G De KJ Meersseman W Van BW Wuyts B Hemelsoet D Pascale H De BJ De PA Poppe B Vanholder R . Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy. Int J Cardiol 2012 Jul 15.","DOI":"10.1016\/j.ijcard.2012.06.069"},{"key":"2025101710571776000_51.1.1.47","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02490607"},{"key":"2025101710571776000_51.1.1.48","doi-asserted-by":"publisher","DOI":"10.1159\/000085709"},{"key":"2025101710571776000_51.1.1.49","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2012.68"},{"key":"2025101710571776000_51.1.1.50","doi-asserted-by":"publisher","DOI":"10.1159\/000250968"},{"key":"2025101710571776000_51.1.1.51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-11-19"},{"key":"2025101710571776000_51.1.1.52","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-005-0369-4"},{"key":"2025101710571776000_51.1.1.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.2012.01092.x"},{"key":"2025101710571776000_51.1.1.54","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2010.25.4.415"},{"key":"2025101710571776000_51.1.1.55","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg194"},{"key":"2025101710571776000_51.1.1.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01166.x"},{"issue":"(Suppl 1)","key":"2025101710571776000_51.1.1.57","first-page":"77","article-title":"[The prevalence of Fabry's disease among male patients on hemodialysis in Lithuania (a screening study)]","volume":"43","author":"Maslauskiene","year":"2007","journal-title":"Medicina (Kaunas)"},{"key":"2025101710571776000_51.1.1.58","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl528"},{"key":"2025101710571776000_51.1.1.59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00160.x"},{"key":"2025101710571776000_51.1.1.60","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2012.669300"},{"key":"2025101710571776000_51.1.1.61","doi-asserted-by":"publisher","DOI":"10.1093\/ndtplus\/sfn009"},{"key":"2025101710571776000_51.1.1.62","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn370"},{"key":"2025101710571776000_51.1.1.63","doi-asserted-by":"publisher","DOI":"10.5414\/CNP64281"},{"key":"2025101710571776000_51.1.1.64","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm532"},{"key":"2025101710571776000_51.1.1.65","doi-asserted-by":"publisher","DOI":"10.5414\/CNP75506"},{"key":"2025101710571776000_51.1.1.66","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.570499"},{"key":"2025101710571776000_51.1.1.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2007.03.008"},{"key":"2025101710571776000_51.1.1.68","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.579409"},{"key":"2025101710571776000_51.1.1.69","doi-asserted-by":"crossref","unstructured":"Dubuc V Moore DF Gioia LC Saposnik G Selchen D Lanthier S . Prevalence of Fabry disease in young patients with cryptogenic ischemic stroke. J Stroke Cerebrovasc Dis 2012 Nov 17;epub ahead of print.","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.10.005"},{"key":"2025101710571776000_51.1.1.70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03739.x"},{"key":"2025101710571776000_51.1.1.71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03737.x"},{"key":"2025101710571776000_51.1.1.72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03227.x"},{"key":"2025101710571776000_51.1.1.73","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.558320"},{"key":"2025101710571776000_51.1.1.74","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-010-0314-5"},{"key":"2025101710571776000_51.1.1.75","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0721-9"},{"key":"2025101710571776000_51.1.1.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.07.011"},{"key":"2025101710571776000_51.1.1.77","doi-asserted-by":"publisher","DOI":"10.1007\/8904_2012_130"},{"key":"2025101710571776000_51.1.1.78","first-page":"101","article-title":"Questioning the pathogenic role of the GLA p.Ala143Thr \u201cMutation\u201d in Fabry disease: implications for screening studies and ERT","volume":"8","author":"Terryn","year":"2012","journal-title":"J Inherit Metab Dis Reports"},{"key":"2025101710571776000_51.1.1.79","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.3.453"},{"key":"2025101710571776000_51.1.1.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.05.003"},{"key":"2025101710571776000_51.1.1.81","first-page":"1186","article-title":"Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease","volume":"53","author":"Eng","year":"1993","journal-title":"Am J Hum Genet"},{"key":"2025101710571776000_51.1.1.82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055565"},{"key":"2025101710571776000_51.1.1.83","doi-asserted-by":"publisher","DOI":"10.1097\/01.icu.0000143688.45232.15"},{"key":"2025101710571776000_51.1.1.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2011.01.014"},{"key":"2025101710571776000_51.1.1.85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01643.x"},{"key":"2025101710571776000_51.1.1.86","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-005-0656-2"},{"key":"2025101710571776000_51.1.1.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2012.06.013"},{"key":"2025101710571776000_51.1.1.88","first-page":"361","article-title":"Evidence for preferential X-chromosome inactivation in a family with Fabry disease","volume":"29","author":"Ropers","year":"1977","journal-title":"Am J Hum Genet"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmedgenet-2013-101857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:57:26Z","timestamp":1760723846000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmedgenet-2013-101857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,6]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,18]]},"published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1136\/jmedgenet-2013-101857"],"URL":"https:\/\/doi.org\/10.1136\/jmedgenet-2013-101857","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,6]]}}}